Introduction
During pregnancy, several hormones and proteins are synthesized and secreted in the maternal circulation by the maternal ovaries, the placenta and the foetus. Some of them are specific to gestation, being detected in maternal blood from the moment when the conceptus becomes more closely attached to the uterine wall and the formation of placentomes begins (Wooding 1992) . Pregnancy-associated glycoproteins (PAG) constitute a large family of molecules specifically expressed in the outer epithelial cell layer of the placenta in eutherian species (Green et al. 2000) . In cattle, the detection of these placenta-associated or placenta-specific proteins in maternal circulation is currently used as an accurate method for pregnancy diagnosis at approximately day 30 after breeding or artificial insemination (AI) (Sasser et al. 1986; Humblot et al. 1988; Zoli et al. 1992; Mialon et al. 1993) . Despite the fact that PAG concentrations can be detected in some pregnant females at earlier gestation periods (Szenci et al. 1998a; Pere´nyi et al. 2002b) , accuracy of pregnancy diagnosis before day 30 after conception can be compromised by individual differences in patterns of PAG secretion by the developing embryo (Pere´nyi et al. 2002b; Chavatte-Palmer et al. 2006) , as well as by a high incidence of embryonic mortality during this critical period (Kummerfeld et al. 1978; Sreenan and Diskin 1983) .
Several bovine, caprine and ovine closely related PAG molecules (63-87% N-terminal amino acid identities) have been made available and have been used to produce antisera for radioimmunoassay (RIA) development (Butler et al. 1982; Camous et al. 1988; Zoli et al. 1991; Garbayo et al. 1998; El Amiri et al. 2003 . Zoli et al. 1991 isolated and characterized a bovine (bo) PAG from fetal cotyledons, with a molecular mass of 67 kDa (NH 2 -terminal sequence: Arg-Gly-Ser-Xxx-LeuThr-Thr-His-Pro-Leu). Antisera were raised in rabbits against this protein (boPAG 67kDa , also named boPAG-1) and a homologous radioimmunoassay system (RIA-497) was developed allowing detection of pregnancy in cattle from day 30 after breeding (Zoli et al. 1992) . Some years later, PAG molecules were isolated from caprine (ca) placental extracts (Garbayo et al. 1998) . A semipurified preparation containing caPAG 55+62kDa (NH 2 -terminal sequences: Ile-Ser-Ser-Pro-Val-Ser-XxxLeu-Thr-Ile and Arg-Asp-Ser-Xxx-Val-Thr-Ile-Val-ProLeu respectively) was used for the production of a polyclonal antiserum (R#706), which has been shown to be able to measure increasing concentrations of PAG in pregnant cows as early as days 21-25 after conception (Pere´nyi et al. 2002b) . Recently, different PAG were isolated from ovine (ov) placentas removed at different gestational periods (El Amiri et al. 2003 . Rabbits were immunized against two preparations containing ovPAG 57+59kDa (NH 2 -terminal sequences: Ile-Ser-SerIIe-Arg-Val-Ser-Xxx-Leu-Thr and Arg-Gly-Ser-AsnLeu-Thr-Ile-His-Pro-Leu for ovPAG 57kDa and ovPAG 59kDa respectively) and ovPAG 55kDa (NH 2 -terminal sequence: Arg-Val-Ser-Xxx-Leu-Thr-Ile-His-ProLeu) and produced antisera R#780 and R#809. However, these new antisera have never been tested for pregnancy diagnosis in bovine species.
Another important feature of ruminant PAG is that they are extensively glycosylated proteins undergoing a complex post-translational processing. Apparent molecular masses of the aforementioned purified PAG have shown a major variability, having higher estimated values (55-67 kDa) than the expected molecular mass of their protein core (37 kDa) (Klisch and Leiser 2003; Klisch et al. 2005) . The variable degree of glycosylation in the different PAG has been claimed to be an important factor regulating the plasma half life of these proteins, including their peripheral concentration (Klisch et al. 2005) . Recent investigations have also demonstrated that various PAG are not expressed coordinately throughout pregnancy (Green et al. 2000; Ushizawa et al. 2004) . Some, for example, are expressed early, others only as pregnancy progresses. Indeed, it has become clear that boPAG-1 may not be expressed in early pregnancy (e.g. day 25); presumably the boPAG-1 antiserum instead recognizes common epitopes in another PAG or PAGs (Green et al. 2000) .
Improvement in existing immunoassay methods for PAG by testing new antisera (Pere´nyi et al. 2002a,b; Green et al. 2005) can be explained by the finding of different phenomena such as the temporal expression of different PAG molecules during early pregnancy, the higher N-terminal amino acid identities but distinct glycosylation patterns (and probably half-life) of PAG molecules purified from bovine, ovine and caprine species, as well as by the specific ability of different antisera to detect PAG during early pregnancy in cattle (Pere´nyi et al. 2002b; Chavatte-Palmer et al. 2006; Lopez-Gatius et al. 2006) . In this study, we designed an experimental protocol to test in parallel five different RIA systems for PAG measurement in peripheral blood to better discriminate the population of pregnant (day 30 after AI) and non-pregnant cows. Additionally, minimum detection limits, reproducibility, accuracy, specificity and parallelism were described in detail.
Materials and Methods
Animals and samples Forty Holstein-Friesian heifers and cows of mixed age and parity were diagnosed as being pregnant by both PAG RIA-497 analysis (day 30 after AI) and rectal exploration (at approximately month 2-3 after AI) and these constituted the pregnant group. The control (nonpregnant) group consisted of 10 Holstein-Friesian cows found to be negative for pregnancy after ultrasonography (Concept/MCV equipped with a 7.5-MHz Linear array; Dynamic Imaging Limited, Livingston, UK) and rectal exploration.
Blood samples (7.5-9.0 ml) from non-pregnant (n ¼ 10) and pregnant females (n ¼ 40) were removed from the coccygeal vein into EDTA-coated tubes (SarstedtÒ, Numbrecht, Germany). Samples from non-pregnant females were collected every 2 days during a stabling period of 2 months in the absence of males. Samples of pregnant females were collected at day 30 after AI. Plasma was obtained by centrifugation (1500 · g for 15 min) immediately after collection and was stored at )20°C until assay.
Concerning the ethical aspects, the experimental procedure was performed completely in vitro except for the blood sampling of the Friesian-Holstein females, which was performed according to good veterinary practice.
PAG radioimmunoassays
Five RIA systems (RIA-497, RIA-706, RIA-780, RIA-809 and RIA-Pool) differing in their antiserum (antibovine PAG 67kDa or R#497; anti-caprine PAG 55+62kDa or R#706 and anti-ovine PAG 57+59kDa and PAG 55kDa or R#780 and R#809) were simultaneously validated for the same criteria and were used to measure PAG concentrations in bovine plasma samples. Bovine PAG 67kDa preparation was used as the standard and tracer for all assays (Zoli et al. 1992) . The standard curve ranged from 0.2 to 25 ng/ml. Iodination (Na-I 125 ; Amersham Pharmacia Biotech, Uppsala, Sweden) was performed according to the Chloramine T method (Greenwood et al. 1963) .
The four aforementioned antisera were mixed (R#497, one part; R#706, one part; R#780, two parts and R#809, two parts) and used as an additional antiserum (Pool) for the comparative validation and for PAG measurement in plasma samples. The first antibody dilutions were, respectively, 1/200 000 for R#497; 1/80 000 for R#706; 1/15 000 for R#780; 1/16 000 for R#809 and 1/64 000 for Pool.
The PAG measurements were performed according to a modified method of Pere´nyi et al. (2002b) . Briefly, standard and plasma samples (0.1 ml) were diluted, respectively, in 0.2 and 0.3 ml of Tris-BSA buffer. Virgin heifer serum (PAG-free serum; 0.1 ml) was added to each tube of the standard curve. After the addition of an appropriate dilution of antisera (0.1 ml), the serum samples and the standard tubes were incubated overnight at room temperature (20-22°C). The following day, 0.1 ml of I 125 -PAG (approximately 25 000 cpm) was added and the tubes were incubated for 4 h at room temperature. After the tubes had been incubated for 30 min at room temperature with 1.0 ml of the second antibody PEG solution, 2.0 ml of Tris-BSA buffer was added and the tubes were centrifuged (20 min at 1500 · g). The supernatant was aspirated and a second wash was carried out with 3.0 ml of Tris-BSA buffer. After centrifugation (20 min at 1500 · g), the tubes were aspirated and the pellet containing the I 125 -PAG bound to the antibodies was counted using a gamma counter (LKB Wallac 126 Multigamma counter, Turku, Finland).
RIA validation Minimum detection limit (MDL)
The MDL was calculated as the mean concentration minus twice the standard deviations (mean ) 2SD) of 10 duplicates of the zero (B 0 ) standard (Skelley et al. 1973) .
Reproducibility
To test the reproducibility of the RIA, two samples with different PAG concentrations were used. Samples were obtained from pregnant cows. Reproducibility was determined by calculating the intra-and inter-assay coefficients of variation (CV) as follows: [%CV ¼ (SD/ mean) · 100]. For intra-assay CV, the same serum was assayed 10 times within the same assay. The inter-assay reproducibility was assessed by analysing each serum in 10 consecutive assays (Rodbard 1974) .
Accuracy
The accuracy for each RIA was determined by adding increasing concentrations of purified boPAG 67kDa (0.5, 1.0, 1.5 and 2.0 ng) to bovine sera containing low PAG concentrations. These amounts were chosen to test the systems in the range of PAG concentrations generally found during early pregnancy. The mean ( ± SD) concentration of each mixture was determined in three duplicates in the same assay. The percentage of recovery was calculated as follows: [observed value (ng/ml)/ expected value (ng/ml)] · 100.
Specificity
The following carbohydrate preparations of commercial origin were used to test the specificity of each RIA: Each carbohydrate was dissolved and then diluted in Tris-BSA buffer to obtain the following concentrations: 1.0, 10 2 , 10 4 and 10 6 ng/ml. For PMSG and hCG, the tested concentrations were 10 )3 , 10 )1 , 10 1 and 10 3 UI/ ml. Each dilution of tested compounds was assayed in triplicate and was considered as an unknown sample. A dilution of a product was considered as crossingreacting if the determined B/B 0 value was lower than the MDL/B 0 value.
Parallelism
This was assessed by serially diluting with PAG-free serum pregnant cow serum containing relatively high PAG concentrations. Parallelism for each RIA system was determined by evaluating a sample at its initial strength (1/1), and at dilutions of 1/2, 1/4 and 1/8.
Pregnancy diagnosis analysis
A cut-off of 0.8 ng/ml was used to discriminate between pregnant and non-pregnant females (Szenci et al. 1998a,b) . The results of the different PAG-RIA systems were arranged as follows: diagnosis pregnant correct (a); diagnosis pregnant incorrect (b); diagnosis not pregnant correct (c) and diagnosis not pregnant incorrect (d).
From these values the sensitivity (100 · a/a + d), the specificity (100 · c/c + b), the positive predictive value (100 · a/a + b) and the negative predictive value (100 · c/c + d) of the pregnancy diagnosis were calculated (Szenci et al. 1998b ).
Statistical analysis
Statistical analyses were carried out in STATA/SE 8 (StataCorp. 2003) . A binomial exact distribution was used to calculate confidence intervals for sensitivity, specificity, positive and negative predictive values. Data relative to sensitivity, specificity, positive and negative predictive values were compared by using the chi-square test. Data relative to PAG were analysed with the procedure mixed of SAS (STAT, Statistical Analysis System 2001) allowing the inclusion of an autovariation between measures performed on the same animal. The state (pregnant vs non-pregnant), RIA system and the interaction state · method were used as factors of variation.
Results
The minimal detection limits calculated for the RIA-497, RIA-706, RIA-780, RIA-809 and RIA-Pool systems were 0.20, 0.26, 0.18, 0.16 and 0.10 ng/ml respectively.
Displacement of the standard (0.2-25 ng/ml) inhibition curves in terms of B/B 0 tested over 15 different assays (mean ± SD) ranged from 94.02 ± 0.64% to 3.49 ± 0.57% (RIA-497), 94.29 ± 0.73% to 4.66 ± 0.68% (RIA-706), 92.15 ± 1.73 to 13.13 ± 3.07% (RIA-780), 97.19 ± 1.88 to 22.41 ± 7.09% (RIA-809) and 93.29 ± 4.92 to 5.09 ± 1.19% (RIA-Pool), with a non-specific binding of below 1% for the five RIA systems (Fig. 1) . The standard curves for RIA-Pool and RIA-497 had the lowest SD for each standard dilution point, while RIA-706 and RIA-809 had the highest. Furthermore, as shown in Fig. 1 , RIA-497 and RIAPool gave the most sensitive curves, RIA-Pool being the superior at the standard points from 0.20 to 0.80 ng/ml.
The reproducibility of the five RIA systems is summarized in Table 1 . In general, intra-assay CV were 1.3-4.9 times lower than those calculated for inter-assay, irrespective of the RIA system used. The use of antiserum R#497 resulted in lower CV in both samples 1 and 2 (3.48-7.48%), whereas antiserum R#809 gave higher values (10.57-20.81%).
The accuracy of the five RIA systems, which is estimated as the recovery of 0.5, 1.0, 1.5 and 2.0 ng of purified boPAG 67kDa added to a bovine serum sample containing low concentrations of PAG, is shown in Table 2 . Higher recovery rates (>98.69%) were obtained by the use of mixed antisera (RIA-Pool), while lower recovery rates were recorded in the case of R#809 Fig. 1 . Displacement of standard inhibition curves (mean ± SD) of pregnancy-associated glycoproteins (PAG) in the five radioimmunoassay systems tested over 15 assays (B/B 0 function of log PAG concentrations) (<92.28%). Parallelism of plasma samples diluted with PAG-free serum is given in Table 3 .
When determined in the presence of different carbohydrates and placental gonadotropins, the binding of radiolabelled PAG was not altered except for high concentrations of N-acetylneuraminic acid (1 mg/ml) and hCG (1000 UI/ml), which slightly interfered in RIA-809 (88.11% and 93.89% of binding respectively).
The PAG concentrations (mean ± SD) determined in plasma samples from pregnant (day 30 after AI) and non-pregnant females are presented in Table 4 . It can be seen that in non-pregnant cows, the RIA-Pool resulted in the lowest and the least variable concentrations (p < 0.05). For samples from pregnant females collected at day 30, all the RIA systems detected PAG concentrations were significantly higher (p < 0.05) than the threshold currently used for pregnancy diagnosis (0.80 ng/ml). In pregnant cows, concentrations of PAG were significantly lower when measured by RIA-497 (p < 0.0001). Concentrations of PAG measured by RIA-Pool were also lower when compared with those measured by RIA-780 (p < 0.0005) and RIA-809 (p < 0.05). All the RIA systems gave 100% sensitivity and negative predictive values (Table 5) . However, as shown in Table 5 , the use of antisera R#780 and R#809 gave significantly lower specificity and positive predictive values (p < 0.002). From a total of 294 samples collected in non-pregnant cows, measurement by RIA-780 and RIA-809 systems resulted in 13 cases (from three different cows) and one case of incorrect pregnancy diagnosis respectively.
Discussion
Early detection of pregnancy combined with a reduction in false-positive diagnosis plays a key role in the achievement of an optimal calving-to-conception interval in dairy and beef cattle. In the same way, improvement in PAG-RIA systems allows the reduction of false-negative diagnosis, and thus the risk of prostaglandin injection in pregnant females. Interest in improving existing immunoassay methods for PAG by testing new antisera have been recently published by Pere´nyi et al. (2002b) and Green et al. (2005) . In the present study, we have described the ability of five RIA systems to detect early pregnancy specifically in cattle. These systems were based on the use of antisera raised against various PAG molecules differing in their molecular masses and species origin.
As reported by Green et al. (2000) , the boPAG-1 (boPAG 67kDa ) mRNA transcripts are not present at day 25 after AI. They first become detectable in bovine placentomes at day 45 after AI. The authors proposed that polyclonal antisera currently used in RIA systems are also able to recognize other PAG molecules, which share common epitope(s) with boPAG-1 and which are expressed earlier in trophoblastic cells. Recently, Pere´nyi et al. (2002b) compared different antisera, revealing higher PAG concentrations by the use of heterologous RIA systems between days 25 and 50 after AI. More recently, a 'sandwich' type of enzyme-linked immunosorbant assay (ELISA) was also made available and was used to detect PAG concentrations in Holstein cows and heifers (Green et al. 2005) . In this system, a mixture of monoclonal antibodies raised against semi-purified PAG molecules produced in early pregnancy (days 24, 34 and 80) was coated in the wells. A polyclonal rabbit antiserum raised against PAG purified from mid-pregnancy cotyledons (day 150) was used to bind the immobilized PAG, this complex being revealed by use of an alkaline phosphatase-conjugated anti-rabbit antibody. The concentrations of PAG measured by ELISA rose rapidly between days 24 and 28 of pregnancy (Green et al. 2005) . However, the ability of this assay to discriminate open and pregnant females in early gestation was not analysed. Despite the use of different antisera raised against PAG purified from different species including bovine, caprine and ovine placenta with a single bovine PAG 67kDa preparation as standard and tracer, the results described in the present study showed that all RIA systems proved to be sensitive, repeatable and accurate for measuring PAG concentrations. The dilutions of sera taken in early pregnancy were parallel to the standard curve. Interestingly, the use of pooled antisera (a mixture of four rabbit antisera against PAG from bovine, ovine and caprine origins) gave the lowest minimal detection limit (0.10 ng/ml). Regarding RIA-497, MDL found in the present study (0.20 ng/ml) was comparable with that described by Zoli et al. (1992) but remains higher than that obtained by Pere´nyi et al. (2002b) (0.05 ng/ml). Similarly, MDL calculated for RIA-706 (0.26 ng/ml) was lower than 0.40 ng/ml reported by Gonzalez et al. (1999) but higher than 0.06 ng/ml as observed by Pere´nyi et al. (2002b) . The differences in MDL values obtained both in the present study and in the previous ones can be ascribed to technical aspects, such as the iodination method, the dilution titres of the first antiserum or the incubation time after the addition of the second antibody precipitation system. Different numbers of N-glycosylation sites of asparagines (consensus sequence: Asn-Xxx-Ser/Thr, where Xxx must not be Pro) have been observed in PAG sequences identified in placentas from eutherian species (Xie et al. 1991; Atkinson et al. 1993; Xie et al. 1997) . For example, in cattle, the dominant boPAG 67kDa form has been shown to present four potential glycosylation sites and 10% of oligosaccharide content , while multi-antennary oligosaccharides have been shown to represent 17.83% of the molecular mass of ovPAG/SBU3 (Atkinson et al. 1993) . In ovine species, the large amounts of lateral chain sugars have been shown to be represented by N-acetyl glucosamine (5.26%), N-acetyl neuraminic acid (4.25%), N-acetyl galactosamine (3.62%), galactose (1.94%) and mannose (1.81%) (Atkinson et al. 1993) . Note that the placental glycoproteins from human (hCG) and equine origins (PMSG) have also been shown to contain several lateral sugar chains (Bahl 1969; Smith et al. 1993 ) probably similar to those observed in the PAG molecules. The specificity test carried out here allowed us to verify the hypothetical interference of isolated carbohydrates and other placental glycoproteins on different PAG-RIA systems. Our results showed that Cross-reactions were only observed in the RIA-809 system when N-acetylneuraminic acid and hCG were tested at very high concentrations (1 mg/ml and 1000 UI/ml respectively).
The measurement of PAG concentrations in peripheral blood is an efficient tool for diagnosing pregnancy in cattle and for following up ongoing pregnancies in physiological (Sasser et al. 1986; Humblot et al. 1988; Zoli et al. 1992 ) and pathological conditions, such as embryonic and fetal mortalities (Semambo et al. 1992; Mialon et al. 1993; Szenci et al. 2000) . The PAG concentrations obtained by RIA-706 (raised against caprine PAG 55+62kDa ), RIA-780 (raised against ovine PAG 57+59kDa ), RIA-809 (raised against ovine PAG 55k-Da) and RIA-Pool were higher than those obtained by RIA-497 (raised against bovine PAG 67kDa ), the most widely cited RIA system used for pregnancy diagnosis in bovine species. At day 30 after AI, all pregnant animals were correctly diagnosed by different PAG-RIA systems while the non-pregnant animals were correctly diagnosed only by RIA-497, RIA-706 and RIA-Pool. Using RIA-780 and RIA-809, concentrations higher than the 0.8 ng/ml threshold were recorded in the peripheral circulation of non-pregnant females at least once during the stabling period in the absence of males (13/294 and 1/294 false-positive diagnoses for RIA-780 and RIA-809 respectively).
In conclusion, the present study clearly shows that the ability of the PAG-RIA system to diagnose pregnancy specifically at day 30 after AI can be improved by using a combination of antisera raised against different forms of PAG. Whether this greater ability to recognize PAG appearing early after fertilization is due to the recognition of different epitopes in the same or in different molecules remains to be elucidated in further investigations. Values with different superscripts differ between rows (p < 0.002). a, diagnosis pregnant correct; b, diagnosis pregnant incorrect; c, diagnosis not pregnant correct; d, diagnosis not pregnant incorrect; Se, sensitivity ¼ 100 · a/a + d; Sp, specificity ¼ 100 · c/c + b; +PV, positive predictive value ¼ 100 · a/ a + b; )PV, negative predictive value ¼ 100 · c/c + d. Confidence intervals (%) are indicated in parenthesis.
